Shin Poong Pharm acquires approval of its modified drug, Pyramax’

Published: 2016-05-23 16:29:00
Updated: 2016-05-23 12:46:20

Shin Poong Pharm(CEO Jae-man Yoo) announced approval of its incrementally modified drug, a child malaria treatment ‘Pyramax Gran’ having pyronaridine phosphate as a main substance from the Ministry of Food and Drug Safety.

Pyramax Gran and Pyramax Tab, products jointly developed by Shin Poong P...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.